These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38634039)
1. Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer. Ma S; Hao R; Lu YW; Wang HP; Hu J; Qi YX Breast Cancer (Dove Med Press); 2024; 16():199-219. PubMed ID: 38634039 [TBL] [Abstract][Full Text] [Related]
2. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation. Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer. Du XJ; Yang XR; Wang QC; Lin GL; Li PF; Zhang WF Heliyon; 2023 Feb; 9(2):e13185. PubMed ID: 36747547 [TBL] [Abstract][Full Text] [Related]
4. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis. Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135 [TBL] [Abstract][Full Text] [Related]
5. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis. Ren H; Shen X; Xie M; Guo X Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940 [TBL] [Abstract][Full Text] [Related]
6. Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer. Li J; Zhang W; Ma X; Wei Y; Zhou F; Li J; Zhang C; Yang Z Front Pharmacol; 2023; 14():1192434. PubMed ID: 37521466 [No Abstract] [Full Text] [Related]
7. Effect of Pyroptosis-Related Genes on the Prognosis of Breast Cancer. Zhou Y; Zheng J; Bai M; Gao Y; Lin N Front Oncol; 2022; 12():948169. PubMed ID: 35957895 [TBL] [Abstract][Full Text] [Related]
8. Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients. Shen HY; Xu JL; Zhu Z; Xu HP; Liang MX; Xu D; Chen WQ; Tang JH; Fang Z; Zhang J Neoplasia; 2023 Nov; 45():100942. PubMed ID: 37839160 [TBL] [Abstract][Full Text] [Related]
9. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C Front Oncol; 2021; 11():640150. PubMed ID: 33869028 [TBL] [Abstract][Full Text] [Related]
10. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway. Li P; Lin Z; Liu Q; Chen S; Gao X; Guo W; Gong F; Wei J; Lin H Front Oncol; 2021; 11():743840. PubMed ID: 34722297 [TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer. Pei J; Li Y; Su T; Zhang Q; He X; Tao D; Wang Y; Yuan M; Li Y Front Genet; 2020; 11():912. PubMed ID: 33193571 [No Abstract] [Full Text] [Related]
12. Comprehensive evaluation of breast cancer immunotherapy and tumor microenvironment characterization based on interleukin genes-related risk model. Lv Y; Bai Z; Wang X; Liu J; Li Y; Zhang X; Shan Y Sci Rep; 2022 Nov; 12(1):20524. PubMed ID: 36443508 [TBL] [Abstract][Full Text] [Related]
13. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer. Yu Z; Zhu Y; Ji J Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486 [TBL] [Abstract][Full Text] [Related]
14. Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma. Huang R; Li Z; Zhang J; Zeng Z; Zhang J; Li M; Wang S; Xian S; Xue Y; Chen X; Li J; Cheng W; Wang B; Yan P; Yang D; Huang Z Front Oncol; 2020; 10():613333. PubMed ID: 33585235 [TBL] [Abstract][Full Text] [Related]
15. Identification of a pyroptosis-related prognostic signature in breast cancer. Chen H; Luo H; Wang J; Li J; Jiang Y BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644 [TBL] [Abstract][Full Text] [Related]
16. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation. Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis. Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087 [TBL] [Abstract][Full Text] [Related]
18. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms. Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D Front Genet; 2021; 12():692953. PubMed ID: 34490033 [No Abstract] [Full Text] [Related]
19. A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration. Tang C; Qin L; Li J Medicine (Baltimore); 2023 Oct; 102(43):e35732. PubMed ID: 37904416 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer. Wang B; Zou D; Wang N; Wang H; Zhang T; Gao L; Ma C; Zheng P; Gu B; Li X; Wang Y; He P; Ma Y; Wang X; Chen H Front Genet; 2022; 13():957655. PubMed ID: 36105100 [No Abstract] [Full Text] [Related] [Next] [New Search]